Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CStone Pharmaceuticals ( (HK:2616) ) just unveiled an announcement.
CStone Pharmaceuticals has announced the composition of its board of directors, detailing the roles and functions of each member. This announcement highlights the company’s commitment to strong governance and strategic oversight, which is crucial for its continued growth and competitiveness in the biopharmaceutical industry.
More about CStone Pharmaceuticals
CStone Pharmaceuticals is a biopharmaceutical company incorporated in the Cayman Islands. It focuses on the development and commercialization of innovative immuno-oncology and precision medicine therapies to address unmet medical needs in cancer treatment.
Average Trading Volume: 12,073,459
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.64B
See more insights into 2616 stock on TipRanks’ Stock Analysis page.